AWM
PTX

AE Wealth Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

AE Wealth Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,500
Closed -$6K – 674
2018
Q4 		$6K Buy
+14,500
New +$9.02K ﹤0.01% 471

AE Wealth Management's PTX Position: Q1 2019 in Review

AE Wealth Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 14,500 shares — an estimated $6K sold.

AE Wealth Management first reported a position in PTX in Q4 2018 and held it in 1 quarter. The position peaked at $6K in Q4 2018. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • AE Wealth Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • AE Wealth Management sold 14,500 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $6K.
  • AE Wealth Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2018 and held it in 1 quarter.
  • AE Wealth Management's Pernix Therapeutics Holdings, Inc. position peaked at $6K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on AE Wealth Management's 13F filing for Q1 2019, filed 14 May 2019.